alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Minority Business Development Agency 

          - [Docket No. 000623192-0192-01] 
          - RIN 0640-ZA07 

# AGENCY:

Minority Business Development Agency, Commerce. 

# ACTION:

Notice. 

# SUMMARY:

                        The Minority Business Development Agency (MBDA) published a document in the                         **Federal Register**                         of June 8, 2000, (65 FR 36411), concerning solicitation of competitive applications from organizations seeking to establish a Minority Business Capital Access Policy Institute (MBCAPI). This document extends the closing date of the award to no later than 5:00 p.m. on July 24, 2000.                     

# DATES:

The closing date for receipt of applications has been extended until July 24, 2000. 

# ADDRESSES:

Applicants must submit one signed original plus two (2) copies of the application. Completed application packages must be submitted to: Office of Financial Access, Room 5600, Minority Business Development Agency, U.S. Department of Commerce, 14th & Constitution Avenue, NW, Washington, DC 20230. 

# FOR FURTHER INFORMATION CONTACT:

Jason Everett at (202) 482-1940. 

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     issue of June 8, 2000, in FR Doc. 65-111, on page 36412, in the first column (second paragraph), change the date from July 10, 2000 to July 24, 2000. Applications will be accepted until 5:00 p.m. Eastern Daylight Time.                

Glenn Clark, 

Financial Management Officer, Minority Business Development Agency. 

Juanita E. Berry, 

Federal Register Liaison Officer, Minority Business Development Agency. 

[FR Doc. 00-16444 Filed 6-28-00; 8:45 am] 

BILLING CODE 3510-21-P
###### Editorial Note on Part 1

#### Editorial Note:

Nomenclature changes to part 1 appear at 63 FR 54077, Oct. 8, 1998.

#### § 1.1508 Awards against other agencies.

If an applicant is entitled to an award because it prevails over another agency of the United States that participates in a proceeding before the Commission and takes a position that is not substantially justified, the award or an appropriate portion of the award shall be made against that agency. Counsel for that agency shall be treated as Bureau counsel for the purpose of this subpart.

[47 FR 3786, Jan. 27, 1982, as amended at 61 FR 39899, July 31, 1996]
698 

699 

700 

701 

702 

703 

704 

705 

706 

707 

708 

709 

710 

711 

712 

713 

714 

715 

716 

717 

718 

719 

720 

721 

722 

723 

724 

725 

726 

727 

728 

729 

730 

731 

732 

733 

734 

735 

736 

737 

738 

739 

740 

741 

742 

743 

744 

745 

746 

747 

748 

749 

750 

751 

752 

753 

754 

755 

756 

757 

758 

759 

760 

761 

762 

763 

764 

765 

766 

767 

768 

769 

770 

771 

772 

773 

774 

775 

776 

777 

778 

779 

780 

781 

782 

783 

784 

785 

786 

787 

788 

789 

790 

791 

792 

793 

794 

795 

796 

797 

798 

799 

800 

801 

802 

803 

804 

805 

806 

807 

808 

809 

810 

811 

812 

813 

814 

815 

816 

817 

818 

819 

820 

821 

822 

823 

824 

825 

826 

827 

828 

829 

830 

831 

    -       - Superintendent of Documents
      - 2010-12-23T16:22:35-0500
      - US GPO, Washington, DC 20401
      - Superintendent of Documents
      - GPO attests that this document has not been altered since it was disseminated by GPO
§ 60-30.13 Consent findings and order. ( a ) *General.* At any time after the issuance of a complaint and prior to or during the reception of evidence in any proceeding, the parties may jointly move to defer the receipt of any evidence for a reasonable time to permit negotiation of an agreement containing consent findings and an order disposing of the whole or any part of the proceeding. The allowance of such deferment and the duration thereof shall be in the discretion of the Administrative Law Judge after consideration of the nature of the proceeding, the requirments of the public interest, the representations of the parties, and the probability of an agreement being reached which will result in a just disposition of the issues involved.
( b ) *Content.* Any agreement containing consent findings and an order disposing of a proceeding shall also provide: ( 1 ) That the order shall have the same force and effect as an order made after full hearing;
( 2 ) That the entire record on which any order may be based shall consist solely of the complaint and the agreement;
( 3 ) That any further procedural steps are waived; and
( 4 ) That any right to challenge or contest the validity of the findings and order entered into in accordance with the agreement is waived.
( c ) *Submission.* On or before the expiration of the time granted for negotiations, the parties or their counsel may: ( 1 ) Submit the proposed agreement to the Administrative Law Judge for his consideration;
( 2 ) Inform the Administrative Law Judge that agreement cannot be reached.
( d ) *Disposition.* In the event an agreement containing consent findings and an order is submitted within the time allowed, the Administrative Law Judge, within 30 days, shall accept such agreement by issuing his decision based upon the agreed findings, and his decision shall consititute the final Administrative order.
[43 FR 49259, Oct. 20, 1978; 43 FR 51401, Nov. 3, 1978]
{"version":"1.0","provider_name":"U.S. Court of Appeals for the Federal Circuit","provider_url":"https:\/\/cafc.uscourts.gov","author_name":"25005pwpadmin","author_url":"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/","title":"2017-2508: Athena Diagnostics, Inc. v. Mayo Collaborative Services - U.S. Court of Appeals for the Federal Circuit","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"9ucKVCLUVR\"><a href=\"https:\/\/cafc.uscourts.gov\/10-04-2018-2017-2508-athena-diagnostics-inc-v-mayo-collaborative-services-audio-uploaded\/\">2017-2508: Athena Diagnostics, Inc. v. Mayo Collaborative Services<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cafc.uscourts.gov\/10-04-2018-2017-2508-athena-diagnostics-inc-v-mayo-collaborative-services-audio-uploaded\/embed\/#?secret=9ucKVCLUVR\" width=\"600\" height=\"338\" title=\"“2017-2508: Athena Diagnostics, Inc. v. Mayo Collaborative Services” — U.S. Court of Appeals for the Federal Circuit\" data-secret=\"9ucKVCLUVR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Oral argument audio posted: Athena Diagnostics, Inc. v. Mayo Collaborative Services (mp3) Appeal Number: 2017-2508 To listen to more oral argument recordings, follow this link: Listen To Oral Arguments."}
99–008 

111TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 2d Session 111–694 

PROVIDING FOR CONSIDERATION OF THE SENATE AMENDMENT TO THE 

HOUSE AMENDMENT TO THE SENATE AMENDMENT TO THE BILL (H.R. 

3082) MAKING APPROPRIATIONS FOR MILITARY CONSTRUCTION, THE 

DEPARTMENT OF VETERANS AFFAIRS, AND RELATED AGENCIES FOR 

THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES 

DECEMBER 21, 2010.—Referred to the House Calendar and ordered to be printed 

Mr. POLIS, from the Committee on Rules, 

submitted the following 

R E P O R T 

[To accompany H. Res. 1782] 

The Committee on Rules, having had under consideration House 

Resolution 1782, by a nonrecord vote, report the same to the House 

with the recommendation that the resolution be adopted. 

SUMMARY OF PROVISIONS OF THE RESOLUTION

The resolution provides for the consideration of the Senate 

amendment to the House amendment to the Senate amendment to 

H.R. 3082, the Continuing Appropriations and Surface Transportation Extensions Act, 2011. The resolution makes in order a motion offered by the chair of the Committee on Appropriations that 

the House concur in the Senate amendment to the House amendment to the Senate amendment to H.R. 3082. The resolution provides one hour of debate on the motion equally divided and controlled by the chair and ranking minority member of the Committee on Appropriations. The resolution waives all points of order 

against consideration of the motion except those arising under 

clause 10 of rule XXI. The resolution provides that the Senate 

amendment shall be considered as read. 

EXPLANATION OF WAIVERS

Although the rule waives all points of order against consideration 

of the motion (except those arising under clause 10 of rule XXI) the 

Committee is not aware of any points of order against the motion. 

The waiver of all points of order against the motion is prophylactic. 

Æ 


jbell on DSKDVH8Z91PROD with REPORTS
##### 



Exhibit 32.2
 CERTIFICATION PURSUANT TO
RULE 13a-14(b) OF THE SECURITIES EXCHANGE ACT OF 1934
AND 18 U.S.C. SECTION 1350
    This certification accompanies the Form 10-K to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not to be incorporated by reference into any filing of
the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether
made before or after the date of the Form 10-K ), irrespective of any general incorporation language
contained in such filing.
 Date: March 13, 2006

/s/ John L. HigginsJohn L. HigginsChief Financial Officer; Executive Vice President,Finance and Corporate Development
{"version":"1.0","provider_name":"U.S. Court of Appeals for the Federal Circuit","provider_url":"https:\/\/cafc.uscourts.gov","author_name":"25005pwpadmin","author_url":"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/","title":"2020-1387: Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc. - U.S. Court of Appeals for the Federal Circuit","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"WqIQVOy8xz\"><a href=\"https:\/\/cafc.uscourts.gov\/11-02-2020-2020-1387-bracco-diagnostics-inc-v-maia-pharmaceuticals-inc-audio-uploaded\/\">2020-1387: Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cafc.uscourts.gov\/11-02-2020-2020-1387-bracco-diagnostics-inc-v-maia-pharmaceuticals-inc-audio-uploaded\/embed\/#?secret=WqIQVOy8xz\" width=\"600\" height=\"338\" title=\"“2020-1387: Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc.” — U.S. Court of Appeals for the Federal Circuit\" data-secret=\"WqIQVOy8xz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Oral argument audio posted: Bracco Diagnostics Inc. v. Maia Pharmaceuticals, Inc. (mp3) Appeal Number: 2020-1387 To listen to more oral argument recordings, follow this link: Listen To Oral Arguments."}
No. 11-5259.

#### Hawkins *v.*Thaler, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

C. A. 5th Cir. Certiorari denied.
Editorial Note on Part 1
Editorial Note: Nomenclature changes to part 1 appear at 63 FR 54077, Oct. 8, 1998.

§ 1.374 The reply case. ( a ) Any party who filed an affirmative case may file and serve a reply case submission within 15 days of the filing of any responsive case submission, unless otherwise directed by the presiding officer.
( b ) The reply case submission shall contain statements of relevant material facts, supported by sworn statements based on personal knowledge, documentation, or by other materials subject to consideration by the presiding officer, and a full legal analysis that responds only to the factual allegations and legal arguments made in any responsive case. Other allegations or arguments will not be considered by the presiding officer.
( c ) Failure to submit a reply case submission shall not be deemed an admission of any allegations contained in any responsive case.
<PAGE>

                                                                      EXHIBIT 23

                         Independent Auditors' Consent



The Board of Directors
PFF Bancorp, Inc.:


We consent to incorporation by reference in the registration statement (No. 33-
20337) on Form S-8 of PFF Bancorp, Inc. of our report dated April 21, 2000,
relating to the consolidated balance sheets of PFF Bancorp, Inc. and subsidiary
as of March 31, 2000 and 1999 and the related consolidated statements of
earnings, comprehensive earnings, stockholder's equity and cash flows for each
of the years in the three-year period ended March 31, 2000, which report appears
in the March 31, 2000, annual report on Form 10-K of PFF Bancorp, Inc.


                                                KPMG LLP



Orange County, California
June 28, 2000
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Neurological Disorders and Stroke Special Emphasis Panel.                    

*Date:*                         January 27, 2000.                    

*Time:*                         2:30 PM to 4:30 PM.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., Bethesda, MD 20892, (Telephone Conference Call).                    

*Contact Person:*                         Philip F. Wiethorn, Scientific Review Administrator, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-9223.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated: January 18, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-1687 Filed 1-24-00; 8:45 am]

BILLING CODE 4140-01-M
{"version":"1.0","provider_name":"U.S. Court of Appeals for the Federal Circuit","provider_url":"https:\/\/cafc.uscourts.gov","author_name":"25005pwpadmin","author_url":"https:\/\/cafc.uscourts.gov\/author\/25005pwpadmin\/","title":"19-1321: SANDERS v. US [OPINION], Nonprecedential - U.S. Court of Appeals for the Federal Circuit","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"GXJoJt2gZS\"><a href=\"https:\/\/cafc.uscourts.gov\/7-15-2019-19-1321-sanders-v-us-opinion-nonprecedential-19-1321-opinion-7-15-2019\/\">19-1321: SANDERS v. US [OPINION], Nonprecedential<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cafc.uscourts.gov\/7-15-2019-19-1321-sanders-v-us-opinion-nonprecedential-19-1321-opinion-7-15-2019\/embed\/#?secret=GXJoJt2gZS\" width=\"600\" height=\"338\" title=\"“19-1321: SANDERS v. US [OPINION], Nonprecedential” — U.S. Court of Appeals for the Federal Circuit\" data-secret=\"GXJoJt2gZS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Opinions\/Orders posted: SANDERS v. US [OPINION](pdf) Appeal Number: 19-1321 Origin: CFC Nonprecedential To see more opinions and orders, follow this link: Opinions and Orders."}
§ 0.204 The exercise of delegated authority. ( a ) *Authority to issue orders and to enter into correspondence.* Any official (or group of officials) to whom authority is delegated in this subpart is authorized to issue orders (including rulings, decisions, or other action documents) pursuant to such authority and to enter into general correspondence concerning any matter for which he is responsible under this subpart or subpart A of this part.
( b ) *Authority of subordinate officials.* Authority delegated to any official to issue orders or to enter into correspondence under paragraph (a) of this section may be exercised by that official or by appropriate subordinate officials acting for him/her.
( c ) *Signature.* ( 1 ) Other orders made by a committee, board or panel identify the body and are signed by the Secretary.
( 2 ) Upon signing an order, the Secretary affixes the Commission's seal.
( 3 ) General correspondence by a committee or board is signed by the committee or board chairperson.
( 4 ) All other orders and letters are signed by the official who has given final approval of their contents.
( 5 ) With the exception of license forms requiring the signature of an appropriate official of the issuing bureau or office, license forms bear only the seal of the Commission.
( d ) *Form of orders.* Orders may be issued in any appropriate form (e.g., as captioned orders, letters, telegrams) and may, if appropriate, be issued orally. Orders issued orally shall, if practicable, be confirmed promptly in writing.
( e ) *Minutes entries.* Except as otherwise provided in this subpart, actions taken as provided in paragraph (d) of this section shall be recorded in writing and filed in the official minutes of the Commission.
[33 FR 8227, June 1, 1968, as amended at 38 FR 18550, July 12, 1973; 62 FR 4170, Jan. 29, 1997; 88 FR 21429, Apr. 10, 2023]
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Quarterly Report of Bank of Florida Corporation (the
Company) on Form 10-Q for the period ended June 30, 2009 as filed with the Securities and Exchange Commission (the Report), I, Tracy L. Keegan, Executive Vice President, Chief Financial Officer and Principal Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | 3. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 4. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for
the period covered by the Report.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |     |  |                            
|-------------------- |  | --- |  | ---------------------------
|Date: August 7, 2009 |  | By: |  | /s/ Tracy L. Keegan        
|                     |  |     |  | Tracy L. Keegan,           
|                     |  |     |  | Principal Financial Officer